


Spinifex
Portfolio Contact: Peter Devine Professor Maree Smith Spinifex is a start-up company from the University of Queensland that is developing a potential first-in-class oral treatment for neuropathic pain and related symptoms without central nervous system side...
Fibrotech
Portfolio Contact: Peter Devine Professor Darren Kelly Fibrotech is a spin-out of the University of Melbourne, developing drugs to treat fibrosis based on the work of Professor Darren Kelly. In April 2014, Fibrotech reached an agreement with Shire...
Hatchtech
Portfolio Contact: Peter DevineWebsite: www.hatchtech.com.au This investment won the Australian Venture Capital Association ‘Best Early Stage Venture Deal of 2016’ and Hatchtech’s human head lice treatment received FDA approval in July...
Recent Comments